inTEST Corp entered into a stock purchase agreement to acquire Alfamation for approximately $20 million in cash and stock, and also restated its financial statements for the quarter ended September 30, 2024 due to revenue overstatement.
AI Assistant
INTEST CORP
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.